ERBB2 and breast cancer: Another group attempted to apply the CRISPR system in breast cancer therapy by targeting the HER2 gene.20 Results showed that targeting HER2-expressing cells inhibited growth and attenuated tumorigenicity, compared to non-targeted cells, suggesting a new therapeutic choice against breast cancer.